Skip to main content

Syndicate contentasthma

Resolvyx announces positive data -- Phase 2 trial of resolvin RX-10045 for dry eye syndrome

BEDFORD, MA ?August, 24, 2009 -- Resolvyx Pharmaceuticals, Inc., the leading resolvin therapeutics company, today announced positive data from a Phase 2 clinical study evaluating RX-10045, a resolvin administered as a topical eye drop for the treatment of patients with chronic dry eye syndrome.

Milk is safe, even encouraged, for some children after treatment for milk allergy

Some children with a history of severe milk allergy can safely drink milk and consume other dairy products every day, according to research led by the Johns Hopkins Children's Center and published in the Aug. 10 online edition of the Journal of Allergy and Clinical Immunology.

They're alive!! Megacities breathe, consume energy, excrete wastes and pollute

WASHINGTON, Aug. 18, 2009 -- A scientific trend to view the world's biggest cities as analogous to living, breathing organisms is fostering a deep new understanding of how poor air quality in megacities can harm residents, people living far downwind, and also play a major role in global climate change.

Interactive asthma education program reduces need for emergency care and steroid use in children

Education on asthma management in children delivered in small, interactive groups improved asthma outcomes and the overall care of children with asthma, found researchers in a study in CMAJ (Canadian Medical Association Journal) http://www.cmaj.ca/press/cmaj080947.pdf (

Discovery may lead to powerful new therapy for asthma

GALVESTON, Texas -- University of Texas Medical Branch at Galveston researchers have found that a single enzyme is apparently critical to most allergen-provoked asthma attacks -- and that activity of the enzyme, known as aldose reductase, can be significantly reduced by compounds that have already undergone clinical trials as treatments for complications of diabetes.

Budesonide is not beneficial for the treatment of diarrhea in metastatic melanoma patients

PHILADELPHIA -- Patients with stage III or IV melanoma taking ipilimumab and the oral steroid budesonide to reduce side effects did not have less diarrhea, a known side effect of ipilimumab, according to results of a phase II trial published in Clinical Cancer Research, a journal of the American Association for Cancer Research.

Scientists make multiple types of white blood cells directly from embryonic and adult stem cells

MADISON -- In an advance that could help transform embryonic stem cells into a multipurpose medical tool, scientists at the University of Wisconsin-Madison have transformed these versatile cells into progenitors of white blood cells and into six types of mature white blood and immune cells.

News briefs from the August issue of Chest

X-RAY MACHINES MAY SPREAD INFECTIONS IN THE ICU

Poor infection control practices when using x-ray machines may lead to nosocomial infections in the ICU. In a new study, Israeli researchers observed 173, 113, and 120 ICU chest x-rays during observation, intervention, and follow-up periods, respectively.

Health reform proposals could help 13 million uninsured young adults gain coverage

New York, NY, August 6, 2009 -- Comprehensive health reform proposals now before Congress could help the more than 13 million uninsured young adults ages 19-29 gain coverage, and such reforms would also help ensure that those who now have coverage would not lose it, according to a new Commonwealth Fund report.

Intense, prolonged exposure to World Trade Center attack linked to new health problems years later

Large number of individuals, such as recovery and rescue workers, nearby residents and office workers, who experienced intense or prolonged exposure to the World Trade Center attack have reported new diagnoses of asthma or posttraumatic stress 5-6 years after the attack, according to a study in the August 5 issue of JAMA, a theme issue on violence and human rights.

Insurance, medical provider do not assure asthma control

It is widely believed that providing better access to medical care can improve the health of Americans. New research at National Jewish Health indicates, however, that having insurance and a medical provider is not enough to improve asthma control among elementary and middle school students.

La Jolla Institute discovers novel tumor suppressor

SAN DIEGO -- (August 3, 2009) La Jolla Institute for Allergy & Immunology researchers studying an enzyme believed to play a role in allergy onset, instead have discovered its previously unknown role as a tumor suppressor that may be important in myeloproliferative diseases and some types of lymphoma and leukemia.

Duke scientists create airway spheres to study lung diseases

DURHAM, N.C. -- Using both animal and human cells, Duke University Medical Center scientists have demonstrated that a single lung cell can become one of two very different types of airway cells, which could lead to a better understanding of lung diseases.

Scientists expect wildfires to increase as climate warms in the coming decades

Cambridge, Mass. -- July 28, 2009 -- As the climate warms in the coming decades, atmospheric scientists at Harvard's School of Engineering and Applied Sciences (SEAS) and their colleagues expect that the frequency of wildfires will increase in many regions. The spike in the number of fires could also adversely affect air quality due to the greater presence of smoke.

Common allergy drug reduces obesity and diabetes in mice

BOSTON, Mass. (July 26, 2009) -- Crack open the latest medical textbook to the chapter on type 2, or adult-onset, diabetes, and you'll be hard pressed to find the term "immunology" anywhere. This is because metabolic conditions and immunologic conditions are, with a few exceptions, distant cousins.



About us

Science Blog was started in August 2002. It lives, breathes and eats press releases from research organizations around the globe. Most of what you read here are press releases from the outfits named in the stories themselves. Got a news story you think belongs here? Let's talk. The other half of the equation is blog posts from readers like you. So if you have an interest in science, please register and join others like you in an ongoing, vibrant dialog about what makes the world tick. Meantime, please take a minute to read our Privacy Policy and Site Disclaimer.


Premium Drupal Themes by Adaptivethemes